Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 194
8
Diseases
34
Unique genes
0.203
Avg. similarity score
Anterior compartment syndrome
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Anterior compartment syndrome
Heme oxygenase deficiency
Pancreatic diseases
heme oxygenase 1 deficiency
Hemolysis
Intracranial vasospasm
Vascular system injury
Diabetic cardiomyopathy
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Anterior compartment syndrome | 5 | 5 | 1 |
| Heme oxygenase deficiency | 5 | 5 | 1 |
| Pancreatic diseases | 5 | 5 | 6 |
| heme oxygenase 1 deficiency | 5 | 5 | 1 |
| Hemolysis | 4 | 4 | 6 |
| Intracranial vasospasm | 3 | 3 | 7 |
| Vascular system injury | 3 | 3 | 10 |
| Diabetic cardiomyopathy | 2 | 2 | 14 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| HMOX1 | 7 / 8 | Anterior compartment syndrome, heme oxygenase 1 deficiency, Heme oxygenase deficiency, Hemolysis and 3 more |
| SPP1 | 3 / 8 | Diabetic cardiomyopathy, Pancreatic diseases, Vascular system injury |
| AGTR2 | 2 / 8 | Diabetic cardiomyopathy, Vascular system injury |
| ATP7A | 2 / 8 | Hemolysis, Vascular system injury |
| LEPR | 2 / 8 | Diabetic cardiomyopathy, Pancreatic diseases |
| TNF | 2 / 8 | Diabetic cardiomyopathy, Vascular system injury |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Diabetic cardiomyopathy | KEGG | 8 / 205 | 13.8× | 7.80e-8 | 5.25e-6 ✓ sig. |
| Hypertrophic cardiomyopathy | KEGG | 6 / 99 | 21.4× | 3.00e-7 | 1.71e-5 ✓ sig. |
| Renin-angiotensin system | KEGG | 4 / 23 | 61.4× | 4.56e-7 | 2.47e-5 ✓ sig. |
| Hormone signaling | KEGG | 7 / 219 | 11.3× | 2.16e-6 | 9.37e-5 ✓ sig. |
| Scavenging of heme from plasma | Reactome | 3 / 13 | 81.5× | 5.82e-6 | 2.15e-4 ✓ sig. |
| Dilated cardiomyopathy | KEGG | 5 / 105 | 16.8× | 1.06e-5 | 3.51e-4 ✓ sig. |
| Peptide ligand-binding receptors | Reactome | 5 / 106 | 16.7× | 1.11e-5 | 3.65e-4 ✓ sig. |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | Reactome | 5 / 125 | 14.1× | 2.46e-5 | 7.08e-4 ✓ sig. |
| G alpha (i) signalling events | Reactome | 6 / 249 | 8.5× | 6.18e-5 | 1.52e-3 ✓ sig. |
| Neuroactive ligand-receptor interaction | KEGG | 7 / 370 | 6.7× | 6.52e-5 | 1.58e-3 ✓ sig. |
| Calcium signaling pathway | KEGG | 6 / 254 | 8.3× | 6.90e-5 | 1.65e-3 ✓ sig. |
| Advanced glycosylation endproduct receptor signaling | Reactome | 2 / 8 | 88.3× | 2.16e-4 | 4.14e-3 ✓ sig. |
| Interleukin-4 and Interleukin-13 signaling | Reactome | 4 / 108 | 13.1× | 2.33e-4 | 4.41e-3 ✓ sig. |
| Pathways of neurodegeneration - multiple diseases | KEGG | 7 / 480 | 5.2× | 3.28e-4 | 5.75e-3 ✓ sig. |
| HDL remodeling | Reactome | 2 / 10 | 70.6× | 3.45e-4 | 5.98e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| vasodilation | GO:0042311 | 6 / 50 | 66.0× | 3.42e-10 | 8.58e-8 ✓ sig. |
| blood vessel remodeling | GO:0001974 | 5 / 42 | 65.4× | 1.19e-8 | 1.99e-6 ✓ sig. |
| positive regulation of cytokine production | GO:0001819 | 5 / 81 | 33.9× | 3.40e-7 | 3.38e-5 ✓ sig. |
| regulation of blood pressure | GO:0008217 | 5 / 83 | 33.1× | 3.85e-7 | 3.75e-5 ✓ sig. |
| nitric oxide-cGMP-mediated signaling | GO:0038060 | 3 / 10 | 165× | 6.55e-7 | 5.87e-5 ✓ sig. |
| positive regulation of smooth muscle cell proliferation | GO:0048661 | 4 / 52 | 42.3× | 2.32e-6 | 1.62e-4 ✓ sig. |
| cellular response to amyloid-beta | GO:1904646 | 4 / 53 | 41.5× | 2.51e-6 | 1.73e-4 ✓ sig. |
| angiotensin-activated signaling pathway | GO:0038166 | 3 / 16 | 103× | 3.03e-6 | 2.01e-4 ✓ sig. |
| regulation of renal output by angiotensin | GO:0002019 | 2 / 2 | 550× | 3.21e-6 | 2.11e-4 ✓ sig. |
| G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger | GO:0007199 | 2 / 2 | 550× | 3.21e-6 | 2.11e-4 ✓ sig. |
| regulation of vasoconstriction | GO:0019229 | 3 / 23 | 71.7× | 9.51e-6 | 5.02e-4 ✓ sig. |
| response to hypoxia | GO:0001666 | 5 / 176 | 15.6× | 1.56e-5 | 7.42e-4 ✓ sig. |
| inflammatory response | GO:0006954 | 7 / 467 | 8.2× | 1.74e-5 | 8.05e-4 ✓ sig. |
| negative regulation of neurotrophin TRK receptor signaling pathway | GO:0051387 | 2 / 4 | 275× | 1.92e-5 | 8.71e-4 ✓ sig. |
| response to macrophage colony-stimulating factor | GO:0036005 | 2 / 4 | 275× | 1.92e-5 | 8.71e-4 ✓ sig. |